Daniel Lynch is of 2seventy bio, Inc.. Currently has a direct ownership of 21,053 shares of TSVT, which is worth approximately $66,527. The most recent transaction as insider was on Jun 13, 2023, when has been sold 8,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K
0% 3M change
0% 12M change
Total Value Held $66,527

DANIEL LYNCH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2023
BUY
Grant, award, or other acquisition
-
8,400 Added 28.52%
21,053 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
7,200 Added 36.27%
12,653 Common Stock
Nov 11 2021
BUY
Grant, award, or other acquisition
-
2,803 Added 33.95%
5,453 Common Stock

Also insider at

SWTX
SpringWorks Therapeutics, Inc. Healthcare
BLUE
bluebird bio, Inc. Healthcare
DL

Daniel Lynch

Stamford,, CT

Track Institutional and Insider Activities on TSVT

Follow 2seventy bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSVT shares.

Notify only if

Insider Trading

Get notified when an 2seventy Bio, Inc. insider buys or sells TSVT shares.

Notify only if

News

Receive news related to 2seventy bio, Inc.

Track Activities on TSVT